DHRS2 and cancer: Previous studies also found a strong up‐regulation of DHRS2 in various cancer cell lines in response to the HDACi LBH589, vorinostat, SAHA, TSA, MS‐275 and CRA‐024781.22, 23, 24 Thus, up‐regulation of DHRS2 is a common effect of HDACi treatments.